Call to Action FOLLOW-UP Letter

If you have sent the second letter,  Thank you! 

If you will be sending it in coming days, please use this updated version.  (The letter is unchanged but two of the recipients requested to be removed from the list.)

Thank you!

May 18, 2012



We have not yet heard from the FDA re: The ME/CFS Stakeholders Meeting. Therefore, we ask everyone to send in a follow up letter. This letter is directed to Dr. Woodcock and is requesting that the stakeholder meeting be held and that we are responded to by June 1. We are urging Dr. Woodcock to preside over this critical meeting.

PLEASE SEND YOUR LETTER BY MAY 25 and urge your relatives and friends to do the same. (Feel free to send more than one letter, even one per day.) A sample template letter and email addresses are included below. Just Copy, Insert your name at the top (and names and address at the bottom) and Paste.

YOUR LETTERS COUNT. Remember – INTENSE LOBBYING & ADVOCACY is how AIDS/HIV got $3 BILLION a year for research, CFS gets $6 million. AIDS/HIV sufferers now have multiple drugs to fight the disease. We have NONE. 

WE MUST STAND UP FOR OURSELVES, and ask family and friends to do the same, We Must Change Our Situation. We must insist that those who work for our benefit listen to us and Act!

For reference, the original sample letter that was sent in late April can be found at these links on Co-Cure and Phoenix Rising.

Thank you everyone, for taking ACTION!

Copy & Paste email addresses

To:, ,, , , ,

The last email address is merely a counter.  Your emails remain private.  Please note: the mailing is limited to requesting the stakeholders meeting. 


Sample Letter to Dr. Woodcock 

From: Your Name                                                                                May 18, 2012

To: Dr. Janet Woodcock, Director, Center for Drug Evaluation and Research

cc:       Secretary Kathleen Sebelius, Department of Health and Human Services; Dr. Margaret Hamburg, Commissioner, FDA, Dr. Howard Koh, Assistant Secretary of Health; Chairman Tom Harkin, Health, Education, Labor, and Pensions, Senator Barbara Mikulski (D-MD), Senator Menendez (D-NJ), Senator Patty Murray (D-WA), Congressman Frank Pallone (D-NJ), Congressman Joseph Pitts (R-PA)

Subject: Request for FDA Stakeholder Meeting on Chronic Fatigue Syndrome

Dear Dr. Woodcock:

We urge you to preside over a stakeholder meeting of the clinicians, researchers, manufacturers, advocacy groups, and patients to engage in a rigorous dialogue to accelerate treatment for ME/CFS.  We ask you to set a date for this meeting by June 1st.

As declared by Dr. Hamburg “FDA has an important role to play in shaping the future of medical breakthroughs by bringing stakeholders together to identify and overcome challenges.” It’s time for the FDA to live up to their role.

As you yourself have stated, “It should be noted that FDA assess the benefit-risk of new drugs on case-by-case basis, considering the degree of the unmet medical need and the severity and morbidity of the condition the drug is intended to treat.”

As one of the millions of people suffering from ME/CFS, I cannot even dream about a better quality of life because there is simply no avenue to get there. I live every day with a disease that the CDC has said is as disabling as multiple sclerosis, heart disease, end-stage renal disease and similar chronic conditions; AND YET THERE ARE ZERO TREATMENTS TODAY. As this falls within your responsibility to address this “unmet medical need” please Act Now.

Your Name


City, State  –  Zip code 


0 Responses to “Call to Action FOLLOW-UP Letter”

  1. Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s